EPIRUBICIN IS A CHEMOTHERAPY DRUG USED TO TREAT A NUMBER OF DIFFERENT CANCERS, PRODUCING RESPONSES IN A WIDE RANGE OF NEOPLASTIC CONDITIONS, INCLUDING BREAST, OVARIAN, GASTRIC, LUNG AND COLORECTAL CARCINOMAS, MALIGNANT LYMPHOMAS, LEUKAEMIAS AND MULTIPLE MYELOMA. EPIRUBICIN IS A CYTOTOXIC ANTHRACYCLINE ANTIBIOTIC AND IS ADMINISTERED INTRAVENOUSLY. IT IS PACKAGED FOR RETAIL SALE.

CLASSIFICATION IS DETERMINED IN ACCORDANCE WITH THE FOLLOWING: GENERAL INTERPRETATIVE RULES (GIRS) GIR 1 HAS BEEN USED TO CLASSIFY THIS PRODUCT BY THE TERMS OF THE HEADING 3004 MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (INCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS FOR RETAIL SALE 3004 AND ANY RELATIVE SECTION OR CHAPTER NOTES. GIR 5(B) HAS BEEN USED AS THE GOODS ARE PACKED IN PACKAGING NORMALLY USED FOR SUCH GOODS. GIR 6 HAS BEEN USED TO CLASSIFY THE GOODS TO SUBHEADING LEVEL. CN CODE 300420000 CONTAINING OTHER ANTIBIOTICS. ALSO CLASSIFIED IN ACCORDANCE WITH SECTION AND CHAPTER NOTES SECTION VI - PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES (CHAPTER 28 - 38) CHAPTER 30 - PHARMACEUTICAL PRODUCTS CHAPTER 30 NOTE 3 - EPIRUBICIN IS AN INN CHEMICAL OF 29419000- ANTIBIOTIC. HARMONISED SYSTEM EXPLANATORY NOTES (A) (B) .